Zinc gluconate

Generic Name
Zinc gluconate
Brand Names
-
Drug Type
Small Molecule
Chemical Formula
C12H22O14Zn
CAS Number
4468-02-4
Unique Ingredient Identifier
U6WSN5SQ1Z
Background

Zinc gluconate is a zinc salt of gluconic acid comprised of two gluconic acid molecules for each zinc cation (2+). Zinc gluconate is a generally recognized as safe (GRAS) substance by FDA . It is available as a trace mineral supplement and over the counter as a lozenge form for a reduced duration of common colds and with decreased symptom severity.
...

Indication

Zinc gluconate is mainly indicated in conditions like zinc deficiency, and can also be administered in adjunctive therapy as an alternative drug of choice in diarrhea .

Associated Conditions
Zinc Deficiency
Associated Therapies
-

Zinc Intervention in Elderly for Prevention of Pneumonia

Phase 2
Completed
Conditions
Interventions
First Posted Date
2022-09-06
Last Posted Date
2024-07-30
Lead Sponsor
Tufts University
Target Recruit Count
105
Registration Number
NCT05527899
Locations
🇺🇸

Jean Mayer USDA Human Nutrition Research Center on Aging, Boston, Massachusetts, United States

Zinc Effect on Inflammation and Cardiovascular Risk in HIV

First Posted Date
2021-10-20
Last Posted Date
2024-10-11
Lead Sponsor
University Hospitals Cleveland Medical Center
Target Recruit Count
95
Registration Number
NCT05085834
Locations
🇺🇸

University Hospitals Cleveland Medical Center, Cleveland, Ohio, United States

The Individual Therapy for Patients With Wilson's Disease

First Posted Date
2019-05-21
Last Posted Date
2019-05-21
Lead Sponsor
Second Affiliated Hospital, School of Medicine, Zhejiang University
Target Recruit Count
400
Registration Number
NCT03957720
Locations
🇨🇳

econd Affiliated Hospital,Zhejiang University School of Medicine, Hangzhou, Zhejiang, China

Improvement of Tinnitus After Oral Zinc on Patients With Noise-induced Hearing Loss

First Posted Date
2016-11-01
Last Posted Date
2016-11-01
Lead Sponsor
Chang Gung Memorial Hospital
Target Recruit Count
20
Registration Number
NCT02951715

Effect of Zinc on Barrett's Metaplasia

Phase 1
Conditions
Interventions
First Posted Date
2013-11-14
Last Posted Date
2013-11-14
Lead Sponsor
Main Line Health
Target Recruit Count
120
Registration Number
NCT01984580
Locations
🇺🇸

Lankenau Institute for Medical Research, Wynnewood, Pennsylvania, United States

Efficacy of Zinc in Reducing Hyperbilirubinemia Among High Risk Neonates - A Double Blind Randomized Trial

Phase 1
Completed
Conditions
Interventions
First Posted Date
2008-06-06
Last Posted Date
2008-06-06
Lead Sponsor
All India Institute of Medical Sciences, New Delhi
Target Recruit Count
294
Registration Number
NCT00692224
Locations
🇮🇳

All India Institute Of Medical Sciences, New Delhi, Delhi, India

© Copyright 2024. All Rights Reserved by MedPath